|
Real-time Estimate
Cboe BZX
11:12:33 2026-09-24 EDT
|
5-day change | 1st Jan Change | ||
| 34.50 USD | -0.73% |
|
+0.10% | +12.24% |
| 07:57am | AbbVie Says Health Canada Issues Notice of Compliance for EPKINLY in Follicular Lymphoma | MT |
| 01:07am | Hansa Biopharma brings in two new board members | FW |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 74.18B | |||||
| 59.55B | |||||
| 25.84B | - | ||||
| 24.73B | - | ||||
| 20.87B |
- Stock Market
- Stocks
- GMAB Stock
- GMAB Stock
- Charts Genmab A/S
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
